Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khusru Asadullah

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Trends in Pharmacological Sciences|September 24, 2004
Techniques: species' finest blend--humanized mouse models in inflammatory skin disease researchFrederik H Igney, Khusru Asadullah, Thomas M Zollner
Trends in Immunology|January 22, 2002
Novel immunotherapies for psoriasisKhusru Asadullah, Hans-Dieter Volk, Wolfram Sterry
Pharmacology & Therapeutics|November 21, 2002
Mechanisms involved in the side effects of glucocorticoidsHeike Schäcke, Wolf Dietrich Döcke, Khusru Asadullah
Drug Discovery Today|December 14, 2011
What makes a good drug target?Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Experimental Dermatology|December 22, 2006
Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach?Thomas M Zollner, Khusru Asadullah, Michael P Schön
Molecular and Cellular Endocrinology|July 17, 2007
Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic indexHeike Schäcke, Markus Berger, Hartmut Rehwinkel, et al.
European Cytokine Network|June 9, 2005
Cytokines as potential therapeutic targets for inflammatory skin diseasesRobert P Numerof, Charles A Dinarello, Khusru Asadullah
Experimental Dermatology|May 13, 2006
Glucocorticoid therapy-induced skin atrophyStefanie Schoepe, Heike Schäcke, Ekkehard May, et al.
Expert Opinion on Drug Discovery|March 20, 2013
Humanised mouse models in drug discovery for skin inflammationFrederik H Igney, Khusru Asadullah, Thomas M Zollner
Expert Opinion on Biological Therapy|July 26, 2003
Cytokine and anticytokine therapy in dermatologyUwe Trefzer, Maja Hofmann, Wolfram Sterry, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Trends in Pharmacological Sciences|September 24, 2004
Techniques: species' finest blend--humanized mouse models in inflammatory skin disease researchFrederik H Igney, Khusru Asadullah, Thomas M Zollner
Trends in Immunology|January 22, 2002
Novel immunotherapies for psoriasisKhusru Asadullah, Hans-Dieter Volk, Wolfram Sterry
Pharmacology & Therapeutics|November 21, 2002
Mechanisms involved in the side effects of glucocorticoidsHeike Schäcke, Wolf Dietrich Döcke, Khusru Asadullah
Drug Discovery Today|December 14, 2011
What makes a good drug target?Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Experimental Dermatology|December 22, 2006
Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach?Thomas M Zollner, Khusru Asadullah, Michael P Schön
Molecular and Cellular Endocrinology|July 17, 2007
Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic indexHeike Schäcke, Markus Berger, Hartmut Rehwinkel, et al.
European Cytokine Network|June 9, 2005
Cytokines as potential therapeutic targets for inflammatory skin diseasesRobert P Numerof, Charles A Dinarello, Khusru Asadullah
Experimental Dermatology|May 13, 2006
Glucocorticoid therapy-induced skin atrophyStefanie Schoepe, Heike Schäcke, Ekkehard May, et al.
Expert Opinion on Drug Discovery|March 20, 2013
Humanised mouse models in drug discovery for skin inflammationFrederik H Igney, Khusru Asadullah, Thomas M Zollner
Expert Opinion on Biological Therapy|July 26, 2003
Cytokine and anticytokine therapy in dermatologyUwe Trefzer, Maja Hofmann, Wolfram Sterry, et al.
Pageof 7